Skip to main content
. 2023 Sep 11;10(4):326–333. doi: 10.1093/ehjqcco/qcad055

Table 2 .

Estimated impact of ABC management on outcomes and costs for AF patients in 2030 and 2040

% of AF patients managed on ABC pathway
20 30 40 50 60 70 80 90 100
2030
Strokes prevented 2758 4137 5516 6895 8274 9653 11 032 12 411 13 790
Cost reduction (£)—strokes 59 908 339 89 862 509 119 816 679 149 770 848 179 725 018 209 679 188 239 633 357 269 587 527 299 541 697
Bleeds prevented 3983 5974 7965 9956 11 948 13 939 15 930 17 921 19 913
Cost reduction (£)—bleeds 27 518 672 41 278 008 55 037 344 68 796 680 82 556 015 96 315 351 110 074 687 123 834 023 137 593 359
Cost reduction (£)—total 87 427 011 131 140 517 174 854 022 218 567 528 262 281 033 305 994 539 349 708 044 393 421 550 437 135 056
Deaths prevented (all cause) 11 945 17 918 23 890 29 863 35 836 41 808 47 781 53 754 59 726
Deaths prevented (CV) 6043 9064 12 086 15 107 18 129 21 150 24 172 27 193 30 214
2040
Strokes prevented 3724 5586 7449 9311 11 173 13 035 14 897 16 759 18 622
Cost reduction (£)—strokes 98 615 026 147 922 539 197 230 052 246 537 565 295 845 078 345 152 591 394 460 104 443 767 617 493 075 130
Bleeds prevented 5378 8067 10 756 13 445 16 134 18 823 21 512 24 201 26 890
Cost reduction (£)—bleeds 45 298 444 67 947 666 90 596 888 113 246 109 135 895 331 158 544 553 181 193 775 203 842 997 226 492 219
Cost reduction (£)—total 143 913 470 215 870 205 287 826 940 359 783 675 431 740 409 503 697 144 575 653 879 647 610 614 719 567 349
Deaths prevented (all cause) 16 131 24 196 32 261 40 326 48 392 56 457 64 522 72 587 80 653
Deaths prevented (CV) 8160 12 240 16 320 20 400 24 481 28 561 32 641 36 721 40 801

CV = cardiovascular